rs145749914

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000284.4(PDHA1):​c.57+2482G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00418 in 867,742 control chromosomes in the GnomAD database, including 97 homozygotes. There are 916 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 61 hom., 584 hem., cov: 23)
Exomes 𝑓: 0.0019 ( 36 hom. 332 hem. )

Consequence

PDHA1
NM_000284.4 intron

Scores

1
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.568

Publications

0 publications found
Variant links:
Genes affected
PDHA1 (HGNC:8806): (pyruvate dehydrogenase E1 subunit alpha 1) The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDH complex is composed of multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodes the E1 alpha 1 subunit containing the E1 active site, and plays a key role in the function of the PDH complex. Mutations in this gene are associated with pyruvate dehydrogenase E1-alpha deficiency and X-linked Leigh syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010]
PDHA1 Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • pyruvate dehydrogenase E1-alpha deficiency
    Inheritance: XL, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
  • Leigh syndrome with leukodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0022673607).
BP6
Variant X-19346576-G-A is Benign according to our data. Variant chrX-19346576-G-A is described in ClinVar as Benign. ClinVar VariationId is 377151.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0636 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDHA1NM_000284.4 linkc.57+2482G>A intron_variant Intron 1 of 10 ENST00000422285.7 NP_000275.1 P08559-1A0A024RBX9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDHA1ENST00000422285.7 linkc.57+2482G>A intron_variant Intron 1 of 10 1 NM_000284.4 ENSP00000394382.2 P08559-1

Frequencies

GnomAD3 genomes
AF:
0.0193
AC:
2161
AN:
111771
Hom.:
61
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0661
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00864
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00195
Gnomad SAS
AF:
0.000736
Gnomad FIN
AF:
0.000165
Gnomad MID
AF:
0.00418
Gnomad NFE
AF:
0.000320
Gnomad OTH
AF:
0.0125
GnomAD2 exomes
AF:
0.00205
AC:
106
AN:
51768
AF XY:
0.000314
show subpopulations
Gnomad AFR exome
AF:
0.0487
Gnomad AMR exome
AF:
0.00244
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00255
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000232
Gnomad OTH exome
AF:
0.00308
GnomAD4 exome
AF:
0.00194
AC:
1466
AN:
755919
Hom.:
36
Cov.:
11
AF XY:
0.00177
AC XY:
332
AN XY:
187189
show subpopulations
African (AFR)
AF:
0.0611
AC:
1033
AN:
16893
American (AMR)
AF:
0.00429
AC:
88
AN:
20534
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14121
East Asian (EAS)
AF:
0.00229
AC:
51
AN:
22315
South Asian (SAS)
AF:
0.00
AC:
0
AN:
25599
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
21845
Middle Eastern (MID)
AF:
0.000604
AC:
2
AN:
3310
European-Non Finnish (NFE)
AF:
0.000175
AC:
105
AN:
598326
Other (OTH)
AF:
0.00567
AC:
187
AN:
32976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
50
100
151
201
251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0194
AC:
2164
AN:
111823
Hom.:
61
Cov.:
23
AF XY:
0.0171
AC XY:
584
AN XY:
34057
show subpopulations
African (AFR)
AF:
0.0660
AC:
2026
AN:
30693
American (AMR)
AF:
0.00863
AC:
91
AN:
10544
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2639
East Asian (EAS)
AF:
0.00195
AC:
7
AN:
3584
South Asian (SAS)
AF:
0.000738
AC:
2
AN:
2709
European-Finnish (FIN)
AF:
0.000165
AC:
1
AN:
6050
Middle Eastern (MID)
AF:
0.00459
AC:
1
AN:
218
European-Non Finnish (NFE)
AF:
0.000320
AC:
17
AN:
53167
Other (OTH)
AF:
0.0124
AC:
19
AN:
1534
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
72
144
215
287
359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00747
Hom.:
45
Bravo
AF:
0.0218
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.00292
AC:
48

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 05, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jun 09, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
1.7
DANN
Benign
0.81
DEOGEN2
Benign
0.0072
.;T
FATHMM_MKL
Benign
0.019
N
LIST_S2
Benign
0.42
T;T
MetaRNN
Benign
0.0023
T;T
MetaSVM
Uncertain
0.28
D
PhyloP100
-0.57
PrimateAI
Benign
0.43
T
PROVEAN
Benign
0.43
N;N
REVEL
Benign
0.24
Sift
Benign
0.10
T;T
Sift4G
Benign
0.30
T;T
Vest4
0.10
MVP
0.52
MPC
1.3
ClinPred
0.0078
T
GERP RS
0.43
gMVP
0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145749914; hg19: chrX-19364694; API